AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36145139 — intervention group
Group type: EXPERIMENTAL
Intervention: C. longa extract group
Number of subjects: 90
Study 36145139 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 90
Study 33297730 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational relaxation therapy (PRT, n=84)
Number of subjects: 138
Study 36169957 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic interprofessional‐led discharge planning tool
Number of subjects: 54695
Study 36169957 — intervention group
Group type: COMPARATOR
Intervention: Standard discharge planning
Number of subjects: 54695
Study 33892316 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab-dkst
Number of subjects: 500
Study 33892316 — intervention group
Group type: COMPARATOR
Intervention: Trastuzumab
Number of subjects: 500
Study 33307218 — intervention group
Group type: EXPERIMENTAL
Intervention: GA area growth rate
Number of subjects: 318
Study 33307218 — intervention group
Group type: EXPERIMENTAL
Intervention: GA perimeter‐adjusted growth rate
Number of subjects: 318
Study 33307218 — intervention group
Group type: EXPERIMENTAL
Intervention: GA perimeter‐adjusted growth rate in eyes with fellow eyes showing GA
Number of subjects: 318
Study 33307218 — intervention group
Group type: COMPARATOR
Intervention: GA perimeter‐adjusted growth rate in eyes with fellow eyes never demonstrating GA
Number of subjects: 318
Study 33017328 — intervention group
Group type: EXPERIMENTAL
Intervention: Training program based on Orem's self‐care deficit nursing theory (SCDNT)
Number of subjects: 102
Study 33017328 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 102
Study 37125984 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based pregnancy prevention intervention
Number of subjects: 73
Study 37125984 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 73
Study 33432503 — intervention group
Group type: EXPERIMENTAL
Intervention: Near-infrared autofluorescence imaging (NIRAF)
Number of subjects: 180
Study 33432503 — intervention group
Group type: COMPARATOR
Intervention: No near-infrared autofluorescence imaging (NONIR)
Number of subjects: 180
Study 32459637 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital telereview (asynchronous and synchronous format)
Number of subjects: 70
Study 32459637 — intervention group
Group type: COMPARATOR
Intervention: Telephone-based telereview (control)
Number of subjects: 70
Study 35470104 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress First Aid (SFA)
Number of subjects: 850
Study 35470104 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 850
Study 33512754 — intervention group
Group type: EXPERIMENTAL
Intervention: Licogliflozin (50 mg once daily)
Number of subjects: 53
Study 35670001 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Training (HIT) in variable contexts (n=19)
Number of subjects: 58
Study 35670001 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Training (HIT) focused on forward walking (n=19)
Number of subjects: 58
Study 35670001 — intervention group
Group type: COMPARATOR
Intervention: Low-Intensity Variable Training (n=20)
Number of subjects: 58
Study 35670001 — intervention group
Group type: EXPERIMENTAL
Intervention: Both HIT groups
Number of subjects: 58
Study 35023598 — intervention group
Group type: EXPERIMENTAL
Intervention: Malleable-prejudice theory story
Number of subjects: 152
Study 35023598 — intervention group
Group type: COMPARATOR
Intervention: Fixed-prejudice theory story
Number of subjects: 152
Study 35023598 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated cross-race interaction
Number of subjects: 152
Study 35023598 — intervention group
Group type: COMPARATOR
Intervention: Same-race interaction
Number of subjects: 152
Study 33075807 — intervention group
Group type: EXPERIMENTAL
Intervention: Kisspeptin (1 nmol/kg/h intravenous infusion over 75 minutes)
Number of subjects: 27
Study 33075807 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (rate‐matched infusion)
Number of subjects: 27
Study 32600452 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegloticase
Number of subjects: 0
Study 32600452 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32600452 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegloticase (in open-label extension)
Number of subjects: 0
Study 35289231 — intervention group
Group type: COMPARATOR
Intervention: Platelet-Rich Plasma (PRP)
Number of subjects: 90
Study 35289231 — intervention group
Group type: COMPARATOR
Intervention: Bone Marrow Aspirate Concentrate (BMC)
Number of subjects: 90
Study 32831303 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemetric, gravimetric platform for real-time physiological phenotyping
Number of subjects: 0
Study 32831303 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback fertigation system
Number of subjects: 0
Study 32831303 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time analytic tool and online statistical resource
Number of subjects: 0
Study 33866916 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotretinoin treatment (mean daily dose 38.7 ± 2.8 mg for 7.20 ± 0.79 months)
Number of subjects: 25
Study 33866916 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy controls)
Number of subjects: 25
Study 35121063 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-Directed Fluid Management (GDFM)
Number of subjects: 104
Study 35121063 — intervention group
Group type: COMPARATOR
Intervention: Liberal Fluid Management (LFM)
Number of subjects: 104
Study 32776169 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted gait training for 2 weeks followed by conventional therapy for 2 weeks
Number of subjects: 63
Study 32776169 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy for 2 weeks followed by robot-assisted gait training for 2 weeks
Number of subjects: 63
Study 32776169 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted gait training
Number of subjects: 63
Study 32776169 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 63
Study 32776169 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy followed by robot-assisted gait training
Number of subjects: 63
Study 32776861 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous music
Number of subjects: 18
Study 32776861 — intervention group
Group type: EXPERIMENTAL
Intervention: Respite music
Number of subjects: 18
Study 32776861 — intervention group
Group type: COMPARATOR
Intervention: No-music control
Number of subjects: 18
Study 36240389 — intervention group
Group type: EXPERIMENTAL
Intervention: Smart Trach laryngoscope
Number of subjects: 375
Study 34176638 — intervention group
Group type: EXPERIMENTAL
Intervention: Screw fixation
Number of subjects: 24
Study 34176638 — intervention group
Group type: EXPERIMENTAL
Intervention: Tightrope fixation
Number of subjects: 24
Study 34176638 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel double Endobutton fixation
Number of subjects: 24
Study 34176638 — intervention group
Group type: COMPARATOR
Intervention: Intact syndesmosis
Number of subjects: 24
Study 35508683 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram model based on the γ‐glutamyl transpeptidase‐to‐albumin ratio (GAR)
Number of subjects: 0
Study 35508683 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram model
Number of subjects: 0
Study 33762220 — intervention group
Group type: EXPERIMENTAL
Intervention: γ-tACS
Number of subjects: 20
Study 33762220 — intervention group
Group type: COMPARATOR
Intervention: sham tACS
Number of subjects: 20
Study 35670045 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous needle electrolysis
Number of subjects: 48
Study 35670045 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling
Number of subjects: 48
Study 35670045 — intervention group
Group type: COMPARATOR
Intervention: Sham needling
Number of subjects: 48
Study 33077012 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone (20-80 mg/day)
Number of subjects: 271
Study 34031118 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced compassion video
Number of subjects: 0
Study 34031118 — intervention group
Group type: COMPARATOR
Intervention: Standard introduction video
Number of subjects: 0
Study 35639143 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics model based on pretreatment MRI
Number of subjects: 216
Study 35639143 — intervention group
Group type: COMPARATOR
Intervention: Clinical prediction model
Number of subjects: 216
Study 35639143 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined radiomics and clinical features model
Number of subjects: 216
Study 35639143 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical‐radiomics model
Number of subjects: 216
Study 34780532 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise (SUP)
Number of subjects: 66
Study 34780532 — intervention group
Group type: COMPARATOR
Intervention: Home-based exercise (HB)
Number of subjects: 66
Study 34780532 — intervention group
Group type: COMPARATOR
Intervention: Supervised plus home-based exercise (SUP+HB)
Number of subjects: 66
Study 34881844 — intervention group
Group type: EXPERIMENTAL
Intervention: Subepithelial connective tissue graft (SCTG) followed by orthodontic treatment
Number of subjects: 36
Study 34881844 — intervention group
Group type: COMPARATOR
Intervention: Orthodontic treatment only
Number of subjects: 36
Study 33270123 — intervention group
Group type: EXPERIMENTAL
Intervention: SLCO1B1 genotyping and results reporting to primary care physicians at baseline (intervention group)
Number of subjects: 408
Study 33270123 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 408
Study 33270123 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with decreased or poor SLCO1B1 transporter function genotype (intervention group)
Number of subjects: 408
Study 33270123 — intervention group
Group type: COMPARATOR
Intervention: Patients with decreased or poor SLCO1B1 transporter function genotype (control group)
Number of subjects: 408
Study 34184401 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calorie formula diet (LCD) for 8 weeks
Number of subjects: 162
Study 32588401 — intervention group
Group type: EXPERIMENTAL
Intervention: Solriamfetol 75 mg
Number of subjects: 231
Study 32588401 — intervention group
Group type: EXPERIMENTAL
Intervention: Solriamfetol 150 mg
Number of subjects: 231
Study 32588401 — intervention group
Group type: EXPERIMENTAL
Intervention: Solriamfetol 300 mg
Number of subjects: 231
Study 32588401 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 231
Study 32588401 — intervention group
Group type: EXPERIMENTAL
Intervention: Solriamfetol (combined)
Number of subjects: 231
Study 32588401 — intervention group
Group type: COMPARATOR
Intervention: Placebo (cataplexy subgroup)
Number of subjects: 231
Study 35869628 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-min brief advice and counseling
Number of subjects: 351
Study 35869628 — intervention group
Group type: COMPARATOR
Intervention: Patient information leaflet (PIL)
Number of subjects: 351
Study 35869628 — intervention group
Group type: COMPARATOR
Intervention: 5-min brief advice
Number of subjects: 351
Study 35869628 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (15-min, 5-min, PIL)
Number of subjects: 351
Study 36170556 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led single-session intervention targeting sociocultural pressures of body image
Number of subjects: 471
Study 36170556 — intervention group
Group type: COMPARATOR
Intervention: Wait list control
Number of subjects: 471
Study 34588232 — intervention group
Group type: EXPERIMENTAL
Intervention: Healing Right Way (HRW) rehabilitation programme
Number of subjects: 0
Study 34588232 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally secure services
Number of subjects: 0
Study 34588232 — intervention group
Group type: EXPERIMENTAL
Intervention: Cultural security training
Number of subjects: 0
Study 34588232 — intervention group
Group type: EXPERIMENTAL
Intervention: Aboriginal Brain Injury Coordinator role
Number of subjects: 0
Study 34588232 — intervention group
Group type: COMPARATOR
Intervention: Control phase
Number of subjects: 0
Study 35916932 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention based on the theory of planned behavior (TPB), consisting of six weekly sessions.
Number of subjects: 162
Study 35916932 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention based on the theory of planned behavior (TPB).
Number of subjects: 162
Study 35916932 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 162
Study 34261332 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital health intervention (DHI) including a smartphone application, smartwatch, and blood pressure monitor for 30 days post-discharge.
Number of subjects: 1064
Study 34261332 — intervention group
Group type: COMPARATOR
Intervention: Control group (historical control).
Number of subjects: 1064
Study 34261332 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital health intervention (DHI).
Number of subjects: 1064
Study 32372570 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsive Parenting (RP) intervention
Number of subjects: 207
Study 32372570 — intervention group
Group type: COMPARATOR
Intervention: Home safety control group
Number of subjects: 207
Study 33976287 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent plasma therapy (two 200 ml transfusions over 24 hours)
Number of subjects: 40
Study 33976287 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 40
Study 33976287 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent plasma therapy
Number of subjects: 40
Study 33377451 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose dexamethasone (oral or intravenous) in adults with COVID-19 requiring oxygen or mechanical ventilation
Number of subjects: 0
Study 33377451 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone
Number of subjects: 0
Study 33377451 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternate equivalent doses of steroids
Number of subjects: 0
Study 33377451 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose corticosteroids
Number of subjects: 0
Study 33377451 — intervention group
Group type: COMPARATOR
Intervention: Convalescent plasma
Number of subjects: 0
Study 33377451 — intervention group
Group type: COMPARATOR
Intervention: Interleukin-6 inhibitors (e.g., tocilizumab)
Number of subjects: 0
Study 33377451 — intervention group
Group type: EXPERIMENTAL
Intervention: Empiric antimicrobial treatment for likely coinfecting pathogens
Number of subjects: 0
Study 33377451 — intervention group
Group type: EXPERIMENTAL
Intervention: Close monitoring without additional empiric antimicrobials
Number of subjects: 0
Study 33377451 — intervention group
Group type: COMPARATOR
Intervention: Hydroxychloroquine ± azithromycin or lopinavir‐ritonavir
Number of subjects: 0
Study 33377451 — intervention group
Group type: COMPARATOR
Intervention: Remdesivir
Number of subjects: 0
Study 32719969 — intervention group
Group type: COMPARATOR
Intervention: Intermittent theta burst stimulation (iTBS), 10 sessions, delivered at 80% of motor threshold, 1,800 pulses, to the right dorsolateral prefrontal cortex.
Number of subjects: 47
Study 32719969 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (control group)
Number of subjects: 47
Study 616508446 — intervention group
Group type: EXPERIMENTAL
Intervention: Right visual field presentation during recognition test
Number of subjects: 0
Study 616508446 — intervention group
Group type: COMPARATOR
Intervention: Left visual field presentation during recognition test
Number of subjects: 0
Study 616508446 — intervention group
Group type: EXPERIMENTAL
Intervention: Acquisition with dominant limb (both left and right-handers)
Number of subjects: 0
Study 33165633 — intervention group
Group type: EXPERIMENTAL
Intervention: LAF (Laminar Air Flow)
Number of subjects: 12
Study 33165633 — intervention group
Group type: COMPARATOR
Intervention: Non-LAF
Number of subjects: 12
Study 32086163 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis use
Number of subjects: 0
Study 34715158 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural Activation (BA) program
Number of subjects: 316
Study 34715158 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion Regulation (ER) program
Number of subjects: 316
Study 34715158 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 316
Study 34587384 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance group (continued antidepressant therapy)
Number of subjects: 478
Study 34587384 — intervention group
Group type: COMPARATOR
Intervention: Discontinuation group (taper and discontinue therapy with placebo)
Number of subjects: 478
Study 34587384 — intervention group
Group type: COMPARATOR
Intervention: Discontinuation group
Number of subjects: 478
Study 34942577 — intervention group
Group type: EXPERIMENTAL
Intervention: PS + UCT
Number of subjects: 594
Study 34942577 — intervention group
Group type: EXPERIMENTAL
Intervention: UCT-only
Number of subjects: 594
Study 34942577 — intervention group
Group type: COMPARATOR
Intervention: Comparison
Number of subjects: 594
Study 34301669 — intervention group
Group type: EXPERIMENTAL
Intervention: High-load resistance training (HL-RT) combined with aerobic training (AT) at 70%-80% of one repetition maximum (1-RM)
Number of subjects: 60
Study 34301669 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-load resistance training (LL-RT) combined with aerobic training (AT) at 30%-40% of one repetition maximum (1-RM)
Number of subjects: 60
Study 34301669 — intervention group
Group type: COMPARATOR
Intervention: Aerobic training (AT) alone as standard care
Number of subjects: 60
Study 33267539 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular injections of muramylpeptide composition
Number of subjects: 40
Study 33267539 — intervention group
Group type: COMPARATOR
Intervention: Oral hygiene instructions, professional oral hygiene procedures, and root scaling
Number of subjects: 40
Study 34711479 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 g L-Citrulline
Number of subjects: 29
Study 34711479 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 32645159 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced reproductive age associated with waist circumference (>88 vs ≤88 cm)
Number of subjects: 1449
Study 32645159 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced reproductive age associated with hemoglobin (≥12 vs <12 g/dL)
Number of subjects: 1449
Study 32645159 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced reproductive age associated with region of residence (sub-Saharan Africa)
Number of subjects: 1449
Study 32645159 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced reproductive age associated with region of residence (Latin America and the Caribbean)
Number of subjects: 1449
Study 32645159 — intervention group
Group type: EXPERIMENTAL
Intervention: Median age at final menstrual period among postmenopausal WWH
Number of subjects: 1449
Study 35738114 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi app and Facebook health tips
Number of subjects: 35
Study 35738114 — intervention group
Group type: COMPARATOR
Intervention: Facebook health tips only
Number of subjects: 35
Study 35738114 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 35
Study 32549135 — intervention group
Group type: EXPERIMENTAL
Intervention: Solid lipid Boswellia serrata particles (SLBSP)
Number of subjects: 0
Study 32549135 — intervention group
Group type: COMPARATOR
Intervention: Standardized Boswellia serrata gum extract (BSE)
Number of subjects: 0
Study 35235993 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth education via WeChat
Number of subjects: 0
Study 35235993 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 35644936 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing a face mask during cardiopulmonary exercise tests (CPET)
Number of subjects: 34
Study 35644936 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing a face mask during CPET
Number of subjects: 34
Study 32737210 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored, face-to-face feedback and help-seeking advice on mental health screening
Number of subjects: 155
Study 34911336 — intervention group
Group type: EXPERIMENTAL
Intervention: Amivantamab + Lazertinib
Number of subjects: 0
Study 34911336 — intervention group
Group type: COMPARATOR
Intervention: Osimertinib
Number of subjects: 0
Study 35278844 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral Gow-gates block
Number of subjects: 0
Study 35278844 — intervention group
Group type: COMPARATOR
Intervention: IV Morphine
Number of subjects: 0
Study 35101958 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial treatment (IAT)
Number of subjects: 649
Study 35101958 — intervention group
Group type: COMPARATOR
Intervention: Intravenous thrombolysis (IVT) preceding IAT
Number of subjects: 649
Study 33991310 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitazoxanide 500 mg BD per oral for 10 days
Number of subjects: 60
Study 33991310 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole 2-2.5 g/day IV for inpatients or 2-2.4 g/day oral for outpatients for 14 days
Number of subjects: 60
Study 35476706 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended antibiotic course (13-14 days duration)
Number of subjects: 324
Study 35476706 — intervention group
Group type: COMPARATOR
Intervention: Standard antibiotic course (5-6 days duration)
Number of subjects: 324
Study 34229149 — intervention group
Group type: EXPERIMENTAL
Intervention: amoxicillin
Number of subjects: 170
Study 34229149 — intervention group
Group type: EXPERIMENTAL
Intervention: ibuprofen
Number of subjects: 170
Study 34229149 — intervention group
Group type: EXPERIMENTAL
Intervention: prednisolone
Number of subjects: 170
Study 34229149 — intervention group
Group type: EXPERIMENTAL
Intervention: amoxicillin plus prednisolone
Number of subjects: 170
Study 34229149 — intervention group
Group type: COMPARATOR
Intervention: metamizole/acetaminophen
Number of subjects: 170
Study 33730519 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 68
Study 33730519 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 36123994 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram model for predicting IVDD risk
Number of subjects: 309
Study 36123994 — intervention group
Group type: COMPARATOR
Intervention: Angiotensin II (AngII) level in peripheral blood
Number of subjects: 309